Infant Formula Biotics and Infection Prevention

In this Danone Nutricia Campus (DNC) video, Prof. Ener Cagri Dinleyici: Professor in Pediatrics in the Eskisehir Osmangazi University reviews the current scientific landscape on biotic‑supplemented infant formulas and their role in the prevention of common pediatric infections. The session places infant nutrition in the context of the first 1000 days, highlighting interactions between diet, gut microbiota, delivery mode, antibiotic exposure, and feeding choices. Building on breastfeeding as the gold standard, the video explores how prebiotics, probiotics, synbiotics, postbiotics, and HMOs are being studied to support infant health when breastfeeding is not possible.

Key Insights for Healthcare Professionals

This resource offers an evidence‑focused overview designed to support clinical decision‑making:

• A structured summary of randomized controlled trials evaluating biotics in infant formula.
• Key findings on infection outcomes, including gastrointestinal and respiratory tract infections.
• Practical differences between prebiotics, probiotics, synbiotics, postbiotics, and HMOs.
• Why results vary by strain, combination, delivery mode, and population.
• Current research gaps, safety considerations, and why clear recommendations are still limited.

Watch on DNC and Deepen Your Knowledge

Watch the full video on DNC to strengthen your understanding of biotic‑supplemented infant formulas and their potential role in infection prevention. Review the session carefully to follow the evidence, limitations, and future research directions. Watch now to access more information available within the full resource.